News
TCMD
9.39
+6.83%
0.60
Tactile Systems Tech's Return On Capital Employed Overview
Benzinga · 3d ago
Wall Street Analysts Believe Tactile Systems Technology (TCMD) Could Rally 188%: Here's is How to Trade
The mean of analysts' price targets for Tactile Systems Technology (TCMD) points to an 187.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does...
Zacks · 11/10 14:55
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Benzinga · 11/09 10:08
IceCure, Allakos top healthcare gainers; NanoString, R1 RCM lead losers' pack
Seekingalpha · 11/08 15:01
BRIEF-Tactile Systems Technology Inc. Reports Third Quarter 2022 Financial Results, Raises Full Year 2022 Outlook
Reuters · 11/07 23:03
Tactile Systems Raises Guidance
Benzinga · 11/07 21:30
Tactile Systems Tech Q3 Sales $65.30M Beat $60.05M Estimate
Benzinga · 11/07 21:29
Tactile Systems GAAP EPS of $0.11, revenue of $65.3M, FY22 guidance above consensus
Seekingalpha · 11/07 21:09
-- Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q3 Loss $-0.11
-- Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q3 Loss $-0.11
MT Newswires · 11/07 16:17
-- Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q3 Revenue $65.3M
-- Earnings Flash (TCMD) TACTILE SYSTEMS TECHNOLOGY Reports Q3 Revenue $65.3M
MT Newswires · 11/07 16:17
Earnings Scheduled For November 7, 2022
Benzinga · 11/07 08:59
Earnings Outlook For Tactile Systems Tech
Benzinga · 11/04 16:14
Tactile Medical to Release Third Quarter of Fiscal Year 2022 Financial Results on November 7, 2022
MINNEAPOLIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, ...
GlobeNewswire · 09/26 11:30
Tactile Medical to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
MINNEAPOLIS, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, ...
GlobeNewswire · 09/06 11:30
--Oppenheimer Adjusts Price Target on Tactile Systems Technology to $18 From $35, Maintains Outperform Rating
--Oppenheimer Adjusts Price Target on Tactile Systems Technology to $18 From $35, Maintains Outperform Rating
MT Newswires · 08/02 09:06
--Piper Sandler Adjusts Price Target on Tactile Systems Technology to $25 From $28, Reiterates Overweight Rating
--Piper Sandler Adjusts Price Target on Tactile Systems Technology to $25 From $28, Reiterates Overweight Rating
MT Newswires · 08/02 05:47
Tactile Systems Technology (TCMD) Reports Q2 Loss, Tops Revenue Estimates
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 12.50% and 4.81%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/01 21:55
Recap: Tactile Systems Tech Q2 Earnings
Tactile Systems Tech (NASDAQ:TCMD) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Tactile Systems Tech reported in-line EPS of $-0.15 versus an estimate of $-0.15.
Benzinga · 08/01 21:26
BRIEF-Tactile Systems Technology Q2 Revenue Up 17% To $59.6 Mln
BRIEF-Tactile Systems Technology Q2 Revenue Up 17% To $59.6 Mln
Reuters · 08/01 21:23
Tactile Systems Tech Q2 EPS $(0.23) Misses $(0.15) Estimate, Sales $59.60M Beat $56.88M Estimate
Tactile Systems Tech (NASDAQ:TCMD) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 428.57 percent decrease over earnings of $0.07 per
Benzinga · 08/01 20:26
More
Webull provides a variety of real-time TCMD stock news. You can receive the latest news about Tactile Systems through multiple platforms. This information may help you make smarter investment decisions.
About TCMD
Tactile Systems Technology, Inc. is a medical technology company focused on developing medical devices for the treatment of chronic diseases. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. It is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. It possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.